President and Founding Chief Executive Officer
Stéphane Bancel is President and Chief Executive Officer of Moderna Therapeutics, a biotechnology company that researches and develops protein therapies based on novel messenger RNA technology. Prior, he was Chief Executive Officer of bioMérieux, a world leader in the diagnostics industry. He was also Managing Director of Eli Lilly in Belgium and Executive Director of Global Manufacturing Strategy and Supply Chain at Eli Lilly in Indianapolis, Indiana. Bancel has been named as an inventor on over 45 patent application filings in the field of messenger RNA technology. He was elected best CEO for investor relations in France in 2009 and was ranked the number one CEO in the biotech sector according to the 2011 Thomson Reuters EXTEL Study. Bancel serves as a Supervisory Director of Qiagen, Executive Chairman of the Board of BG Medicine and is on the Board of Directors of Syros Pharmaceuticals. He holds an MA in Engineering from École Central Paris, an MSc in Chemical Engineering from the University of Minnesota and an MBA from Harvard Business School.